---
title: "Pirfenidone - Hamman-Rich Syndrome"
sidebar: mydoc_sidebar
permalink: db04951-mesh-d000080203-1.html
toc: false 
---


Path ID: `DB04951_MESH_D000080203_1`
{% include image.html url="images/db04951-mesh-d000080203-1.png" file="db04951-mesh-d000080203-1.png" alt="db04951-mesh-d000080203-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C093844 | Pirfenidone | Drug |
| UniProt:P01375 | Tumor necrosis factor | Protein |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D016212 | Transforming Growth Factor beta | ChemicalSubstance |
| GO:0048144 | Fibroblast proliferation | BiologicalProcess |
| MESH:D000080203 | Hamman-Rich syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pirfenidone | DECREASES ACTIVITY OF | Tumor Necrosis Factor |
| Pirfenidone | DECREASES ACTIVITY OF | Transforming Growth Factor Beta |
| Pirfenidone | NEGATIVELY REGULATES | Fibroblast Proliferation |
| Tumor Necrosis Factor | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Hamman-Rich Syndrome |
| Transforming Growth Factor Beta | POSITIVELY CORRELATED WITH | Hamman-Rich Syndrome |
| Fibroblast Proliferation | POSITIVELY CORRELATED WITH | Hamman-Rich Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Pirfenidone#Mechanism_of_action](https://en.wikipedia.org/wiki/Pirfenidone#Mechanism_of_action)
  - [https://go.drugbank.com/drugs/DB04951](https://go.drugbank.com/drugs/DB04951)
